CCRT+PF

DRUG2 trials

Sponsors

Sun Yat-sen University, Guiyang Medical University

Conditions

Locally Advanced Nasopharyngeal CarcinomaNasopharyngeal Carcinoma

Phase 3

Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma

Sun Yat-sen UniversityNasopharyngeal Carcinoma

Start: 2017-10-30End: 2025-12-31Target: 216Updated: 2023-05-22

TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC

Guiyang Medical UniversityLocally Advanced Nasopharyngeal Carcinoma

Start: 2018-05-24End: 2023-05-24Target: 266Updated: 2018-07-02

Related Papers

Induction TPF versus adjuvant PF after CCRT in locally advanced nasopharyngeal carcinoma: A multicenter, randomized controlled phase III clinical trial.

2026-08-16

A multicenter, randomized controlled phase III trial of TPF induction chemotherapy versus PF adjuvant chemotherapy combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: Long-term follow-up analysis.

Journal of Clinical Oncology2026-05-27

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.

2023-06-0527 citations

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-5-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: A multicentre, open-label, randomised, controlled, phase 3 trial.

Journal of Clinical Oncology2023-06-01